Chemical subgroup
N03AX – Andere Antiepileptika
13Decisions
13Patient groups
Added benefit by patient group
- Considerable2
- Not proven11
Decisions, newest first
- 2024-05-16EpidyolexCannabidiolNot proven
- 2024-05-16EpidyolexCannabidiolNot proven
- 2024-05-16EpidyolexCannabidiolNot proven
- 2023-08-03FinteplaFenfluraminConsiderable
- 2022-09-01Briviact (in Italy: Nubriveo)BrivaracetamNot proven
- 2021-11-19OntozryCenobamatNot proven
- 2021-07-15FinteplaFenfluraminConsiderable
- 2021-06-03FycompaPerampanelNot proven
- 2021-06-03FycompaPerampanelNot proven
- 2019-01-17Briviact (in Italy: Nubriveo)BrivaracetamNot proven
- 2018-05-17FycompaPerampanelNot proven
- 2016-08-04Briviact (in Italy: Nubriveo)BrivaracetamNot proven
- 2014-11-06FycompaPerampanelNot proven
Data status: 2026-10-29